DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use (DOKTORBRAU)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Usually, dual task tests are only achieved on electronic treadmills. Patients who are coming to perform these tests are mainly subjects with various levels of cognitive disorders and with a high risk of fall because of potential motor and cognitive disorders.
The investigator will select patients referred for double task walking tests. After the walking test, investigator will perform dual-task tests with a new bicycle device "Cycléo BRAU" which allows the patients to achieve mental tasks while cycling. The aim of using a bicycle is to limit the risk of falls compared to the treadmill or walking task. The "Cycléo BRAU" device is equiped with a video projector which projects an environment of virtual reality. It allows cycling without resistence and thus is not based on any incremental worload. The mental tasks on bicycle will be of increasing difficulty and parameters such as cycling speed will be recorded. Loss of speed regularity will be considered as an abnormal response. The task for which cycling is stopped will be recorded and compared to the results of the usual walking test.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Angers, France, 49933
- CHU Angers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 60 years old
- Patient with a near visual acuity upper or equal to 2/10
- Patient with a score of MMSE upper than 10
- Patient able to walk on a treadmill for 15 meters on straight line without help
- Patient covered by the French health insurance
- Patient (or support person or legal representative) able to understand the protocol
- Patient (or support person or legal representative) agrees to be involve in the protocol and sign the consent form
Exclusion Criteria:
- Patient has a wash-out period for another clinical trial
- Patient with a medical contraindication to practice bicycle
- Patient with locomotor disorders preexisting, whatever the reason
- Patient needing extern help to walk like a walking frame, rollator or tricycle
- Patient with a medical or surgical disease acute from less of 3 months
- Patient with cerebrovascular accident history or any other cerebro-medullary diseases with sensorimotor consequences
- Patient with severe depression (Geriatric Depression Scale 15 items upper than 10)
- Patient with a low proficiency of French (oral or written)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Practice dual-task tests
The study consists to practice these dual-task tests with a new device which name is "Cycléo BRAU" that allows to the patients to achieve carefully an attentional task: cycle.
Results will be compared tothe results obsvered during the routine GAITRITE analysis ( a validated tool for elderly patients and gait analysis).
|
Practice dual-task tests.
Routine practice dual-task tests.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speed
Time Frame: 12 months
|
Evaluate the concordance of the speed during the tests on treadmill and on cyclo-ergometer.
|
12 months
|
|
Speed variability
Time Frame: 12 months
|
Evaluate the concordance the speed variability during the tests on treadmill and on cyclo-ergometer.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pierre ABRAHAM, MD; PhD, University Hospital in Angers
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.